Skip to content

Effectivenessof L-Arginine supplementation for treatment of patients with pulmonary tuberculosis

Randomized, Double-Blind, Placebo-Controlled Trial of L-Arginine Supplementation for the treatment of pulmonary Tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201211179855N2
Enrollment
60
Registered
2013-01-10
Start date
2012-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis. Tuberculosis of lung, confirmed by sputum microscopy with or without culture

Interventions

Intervention 1: In case group Standard anti-tuberculosis treatment for 6 months plus l- arginine, 2 g daily in first month. Intervention 2: In control group 6-month Anti-TB treatment plus placebo 2gra
Treatment - Drugs
In case group Standard anti-tuberculosis treatment for 6 months plus l- arginine, 2 g daily in first month
In control group 6-month Anti-TB treatment plus placebo 2gram daily in first month

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: adults over 15 years ;New cases of positive sputum smear Exclusion criteria: pregnant women ; aged under 15 years, ;patients who During the past month received L-arginine ; Sensitivity to L - arginine

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improved paraclinical tests. Timepoint: days of 14 , 28 , 42 , 56. Method of measurement: check of CRP.;Improved paraclinical tests. Timepoint: days of 14 , 28 , 42 , 56. Method of measurement: check of ESR.;Improved paraclinical tests. Timepoint: days of 14 , 28 , 42 , 56. Method of measurement: check of CBC.

Secondary

MeasureTime frame
Improve of life quality. Timepoint: 0 and 56. Method of measurement: standard questionairof GHQ-28.;Accelerating weight gain. Timepoint: 0 AND56. Method of measurement: Weight measurement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhazaleh Akbarifard

Arak University of Medical Sciences

gakbarifard@yahoo.com+98 86 1417 3645

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 5, 2026